Catheter Precision, Inc. (VTAK)
- Previous Close
0.4200 - Open
0.4400 - Bid 0.4302 x 1800
- Ask 0.4380 x 800
- Day's Range
0.4120 - 0.4390 - 52 Week Range
0.3100 - 8.4000 - Volume
79,463 - Avg. Volume
3,596,114 - Market Cap (intraday)
3.475M - Beta (5Y Monthly) --
- PE Ratio (TTM)
0.16 - EPS (TTM)
2.7800 - Earnings Date Nov 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.00
Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.
www.catheterprecision.comRecent News: VTAK
View MorePerformance Overview: VTAK
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VTAK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VTAK
View MoreValuation Measures
Market Cap
3.36M
Enterprise Value
3.98M
Trailing P/E
0.15
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.12
Price/Book (mrq)
0.26
Enterprise Value/Revenue
9.97
Enterprise Value/EBITDA
0.09
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-21.56%
Return on Equity (ttm)
-49.81%
Revenue (ttm)
436k
Net Income Avi to Common (ttm)
-9.49M
Diluted EPS (ttm)
2.7800
Balance Sheet and Cash Flow
Total Cash (mrq)
16k
Total Debt/Equity (mrq)
5.67%
Levered Free Cash Flow (ttm)
-3.91M